Association Between Coronary Artery Disease and Plasma Omentin-1 Levels
- PMID: 34567888
- PMCID: PMC8454460
- DOI: 10.7759/cureus.17347
Association Between Coronary Artery Disease and Plasma Omentin-1 Levels
Abstract
Introduction: Omentin-1 is secreted from visceral adipose tissue that contributes to chronic inflammatory diseases' pathogenesis, including cardiovascular events. In this case-control study, we will determine the association between plasma omentin and coronary artery disease (CAD).
Methods: This is a case-control study, conducted from June 2020 to April 2021 in the cardiology unit of a tertiary care hospital in Pakistan. Patients diagnosed with CAD (n = 300) within the last six months were included in the study. Another 300 participants without CAD and with similar demographic profiles were included in the control group. A blood sample of 5 ml was drawn from participants of both groups and sent to the laboratory to test for plasma omentin level.
Results: Plasma omentin level was significantly lower in patients with CAD compared to the patients without CAD (61.21 ± 10.21 ng/dL vs. 95.22 ± 12.21 ug/L; p-value: <0.0001). In both genders, the plasma omentin-1 was lower in patients with CAD compared to patients without CAD (p-value: <0.0001).
Conclusion: The present study revealed a negative association between omentin-1 and CAD. We speculate that low levels of omentin-1 might play a role in the pathogenesis of atherosclerosis. Therefore, plasma omentin-1 can be a potential biomarker to predict the development and progression of CAD.
Keywords: cad; cardiovascular disease; coronary artery disease; intelectin-1; omentin-1.
Copyright © 2021, Bai et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. GBD 2013 Mortality and Causes of Death Collaborators. https://pubmed.ncbi.nlm.nih.gov/25530442/ Lancet. 2015;385:117–171. - PMC - PubMed
-
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Yusuf S, Hawken S, Ounpuu S, et al. https://pubmed.ncbi.nlm.nih.gov/15364185/ Lancet. 2004;364:937–952. - PubMed
-
- Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches. Siasos G, Tsigkou V, Kokkou E, et al. Curr Med Chem. 2014;21:3936–3948. - PubMed
-
- Type-2 diabetes mellitus and cardiovascular disease. Henning RJ. Future Cardiol. 2018;14:491–509. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous